Tests in Biological Technology

Axial Biotech Enters Partnership with the University of Utah to Utilize the Utah Population Database to Develop Personalized Diagnostic Tests for Spine Disorders

SALT LAKE CITY, July 22 /PRNewswire/ -- Axial Biotech, Inc., a company personalizing spine care through the development of molecular diagnostics, and the University of Utah today announced that they have entered into a collaboration that allows Axial access to the University's rich ...

Magellan Diagnostic Businesses to Feature Automated Systems and Diagnostic Tests at Clinical Lab Expo

CHELMSFORD, Mass., July 16 /PRNewswire/ -- Magellan Biosciences, an emerging leader in clinical diagnostics, will feature a variety of automated systems and diagnostic tests designed to help doctors make faster, more-informed treatment decisions in Booth 3244 at the 2009 AACC/ASCLS Cli...

Exosome Diagnostics and DxS Diagnostic Innovations Collaborate to Develop Blood-Based Tests for Key Cancer Mutations

NEW YORK, June 22 /PRNewswire/ -- Exosome Diagnostics, Inc. ("ExosomeDX") and DxS Ltd. ("DxS") today announced that they will collaborate on the development of blood-based companion diagnostics for key cancer gene mutations, such as KRAS, BRAF and EGFR. The collaboration will use DxS' industry le...

Agendia Supports Genentech's Citizen's Petition Urging FDA to Hold In-Vitro Diagnostic Tests to One Set of Scientific and Regulatory Standards

HUNTINGTON BEACH, California, and AMSTERDAM, May 28 /PRNewswire/ -- Agendia, a world leader in molecular cancer diagnostics, today announced its strong support of Genentech's Citizen's Petition. Filed on December 5, 2008, Docket No. FDA-2008-P-0638-0001/CP petitions that all in vitro diagnosti...

Transgenomic and Power3 Medical Introduce NuroPro(R) Tests for Alzheimer's and Parkinson's Diseases at AAN Annual Meeting

Collaboration with Noted Neurologists to Plan Next Clinical Studies OMAHA, Neb. and HOUSTON, May 11 /PRNewswire-FirstCall/ -- Transgenomic, Inc. (OTC Bulletin Board: TBIO) and Power3 Medical Products, Inc. (OTC Bulletin Board: PWRM), announced the clinical introduction of the NuroPro(R) AD an...

New White Paper Examines Advanced Mycoplasma Tests - How Real-Time PCR Analysis Helps Save Time and Money for Biopharmaceutical Manufacturers

AGAWAM, Mass., March 16 /PRNewswire/ -- Contamination by mycoplasmal organisms is an ever-present concern in biopharmaceutical manufacturing. Their properties make them ready sources of contamination, while rendering them difficult and time-consuming to detect. A new free white paper, examines how...

Gene Signal Enters Phase III Clinical Tests for the Prevention of Corneal Graft Rejection

- Gene Signal International, a Biotech Company Registered in Switzerland, Will Move its Headquarter to the EPFL, in Lausanne, - Gene Signal is Addressing Various Issues Related to Neovascularisation, - Gene Signal is Working on a Portfolio of Ophthalmologic Indications, With One Now...

Lumiphore Partners with Biophor Diagnostics, Inc. to Develop Tests for Drugs of Abuse; Appoints Ibis Biosciences Founder David J. Ecker to Board

RICHMOND, Calif., Oct. 1 /PRNewswire/ -- Lumiphore, Inc., a biotechnology leader in the development of new proprietary fluorescent metal-lanthanide technology for use in high-value applications, announced that it has signed an exclusive agreement with Biophor Diagnostics, Inc., Redwood City, C...

Rosetta Genomics Announces Three New Diagnostic Tests to Enter Development

New Development Programs to Include Response Prediction to Ovarian Cancer Treatment, Predicting Risk of Gastric Cancer Recurrence, and Differentiation of Small Cell From Non-Small Cell Lung Cancer In Addition, the Company has Identified Unique microRNA Biomarkers in the Serum of Colon ...

3M Discontinues Collaboration with Gen-Probe to Develop Molecular Tests for Healthcare-Associated Infections

ST. PAUL, Minn. and SAN DIEGO, June 16 /PRNewswire-FirstCall/ -- 3M and Gen-Probe Incorporated (Nasdaq: GPRO ) announced today that 3M has discontinued the companies' collaboration to develop rapid molecular tests for healthcare-associated infections (HCAIs). The companies, which are explor...

Making a good impression: Nanoimprint lithography tests at NIST

In what should be good news for integrated circuit manufacturers, recent studies by the National Institute of Standards and Technology (NIST) have helped resolve two important questions about an emerging microcircuit manufacturing technology called nanoimprint lithographyyes, it can accurately sta...

Genetic Testing for All: QTrait Offers Industry's Least Expensive, Most Secure DNA Tests With TRUSTe Certification

SEATTLE, April 24 /PRNewswire/ -- iGenix, Inc, today launched QTrait, a personal online genetics testing service with prices beginning as low as $99 per DNA test. iGenix co-founder and chief scientist Tera Eerkes, Ph.D. developed QTrait to create affordable DNA testing for the general public, ...

Center for Molecular Medicine Partners with AviaraDx to Offer New Cancer Tests to Aid Physicians in Personalizing Treatment

Tests Improve Cancer Identification, Help Physicians Develop More Specific Prognosis GRAND RAPIDS, Mich., March 3 /PRNewswire/ -- The Center for Molecular Medicine (CMM) today announced an agreement with San Diego-based AviaraDx to support three new tests that help...

Data Presented on Monogram HIV Tropism Tests at Retrovirus Conference sets New Standards of Assay Sensitivity

Company Continues to Lead Tropism Testing Field SOUTH SAN FRANCISCO, Calif., Feb. 7 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc (Nasdaq: MGRM ) today announced that data related to the company's advanced HIV tropism assay have been presented as multiple posters during the ...

EpiStem Successfully Complete First Year of Mucositis Tests for NIH Biodefence Programme

MANCHESTER, England, September 20 /PRNewswire-FirstCall/ -- EpiStem (LSE: EHP) announced today that it has completed the first year of mucositis efficacy-testing services for potential biodefense drugs, and are about to embark upon an extensive drug screening programme over the coming year. T...

BRAHMS, Cezanne and Lumiphore Announce Partnership for Diagnostic Tests

BERLIN, NIMES, France and RICHMOND, Calif., June 22 /PRNewswire/ -- BRAHMS Aktiengesellschaft, a global diagnostics company, Cezanne, and Lumiphore Inc., a biotechnology leader in new proprietary fluorescent metal-lanthanide technology for use in high-value applications, announced that they have ...

SD Canada Announces CE Mark for ThyroChek(R) Adult and NeoNatal Tests

Rapidly growing thyroid test market expands to EU, LATAM and Africa SAINT JOHN, New Brunswick, March 11 /PRNewswire/ -- Screening Devices Canada, Inc. announces the immediate availability of ThyroChek, the rapid test for elevated TSH, the first clinical indicator of hypothyroidism to countrie...

Data Presented at Cancer Molecular Markers Meeting Suggests Clinical Benefit for Integrating New Molecular Tests

SUNNYVALE, Calif., Oct. 31 /PRNewswire/ -- Pathwork Diagnostics, a molecular diagnostics company focused on oncology, and City of Hope Hospital presented today the results from a meta-analysis examining the use of immunohistochemistry (IHC) to determine the origin of metastatic cancer at the se...

Diagenic Partners With DNAVision to Offer First Breast Cancer and Alzheimers Gene-Expression Blood Tests

OSLO, October 28 /PRNewswire-FirstCall/ -- DiaGenic ASA (OSL:DIAG) today announced that it has signed a service provider agreement with DNAVision, a leading panEuropean provider of gene expression-based diagnostic testing and services With this laboratory service and following CE marking sched...

World Sight Day - Britons at Risk of Losing Their Sight by Not Having Regular Eye Tests

Glaucoma Leading Cause of Preventable Blindness in the UK(1) Though Awareness of Symptoms and Risk Factors Remains Low WALTON OAKS, England, October 9 /PRNewswire/ -- Today on World Sight Day leading experts aim to raise awareness of the eye disease glaucoma. It is estimated that t...

Interleukin Genetics and Alticor Agree on Expansion of Distribution Channels for Genetic Tests

Interleukin Genetics Plans to Continue Efforts to Out-License Intellectual Property WALTHAM, Mass., Sept. 4 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (Amex: ILI ), and Access Business Group International LLC, a division of Alticor Inc., have reached an...

Roche and Response Biomedical Corporation Aim to Reduce 'Vein-to-Brain' Time with New Point-of-Care Cardiac Tests

Roche will market the RAMP(R) cardiovascular product line in the United States and Canada INDIANAPOLIS, July 28 /PRNewswire/ -- Roche Diagnostics and Response Biomedical have entered into a partnership that will allow Roche to market the first line of cardiovascular t...

Rosetta Genomics Executes Binding Term Sheet to Acquire U.S. CLIA-Certified Lab to Expedite Commercialization of Diagnostic Tests

Rosetta Genomics has Signed a Binding Term Sheet to Acquire Parkway Clinical Laboratories Inc., a Company Owning a Clinical Laboratory Improvement Act (CLIA) Certified Lab The Acquisition is Intended to Significantly Streamline the Development and Commercialization of Rose...

LabCorp(R) and Vanda Pharmaceuticals Collaborate to Offer Genetic Tests

BURLINGTON, N.C. and ROCKVILLE, M.D., June 5 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH ), one of the world's leading clinical trials and genetic testing laboratories, and Vanda Pharmaceuticals Inc. (Nasdaq: VNDA ), a biopharmaceutical comp...

Roche Signs Exclusive Distribution Deal with DxS for K-RAS and EGFR Cancer Mutation Tests

Tests identify genetic mutations that can affect patient response to certain cancer drugs PLEASANTON, Calif., June 2 /PRNewswire/ -- Roche and DxS Ltd. have signed an exclusive distribution agreement for the DxS TheraScreen K-RAS Mutation Test and TheraScreen EGFR 29...

Vermillion and Johns Hopkins Sign Collaborative Research and License Agreements to Develop Molecular Diagnostic Tests

Vermillion Obtains Exclusive Rights to Oncology Biomarkers FREMONT, Calif., Feb. 6 /PRNewswire-FirstCall/ -- Vermillion, Inc. (Nasdaq: VRML ), a high-value molecular diagnostics company, today announced the renewal of a long-standing collaboration with Johns Hopkins University on the d...

Kiwa Fertilizers Pass Independent Tests

BEIJING and CLAREMONT, Calif., Jan. 7 /Xinhua-PRNewswire-FirstCall/ -- Kiwa Bio-Tech Products Group Corporation (KWBT.OB) announced that: Xinjiang Corps Agro-technology Extended Terminal promulgated the test results on Kiwa's fertilizer products "Pen Duo Shou" and "Jin Peng Jia Bao", both of w...

ANX-514 Reduces Hypersensitivity Reactions Without Impacting Pharmacokinetics or Antitumor Activity in Preclinical Tests

ADVENTRX Presents Results at 2007 AACR-NCI-EORTC International Conference SAN DIEGO, Oct. 25 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (Amex: ANX ), a biopharmaceutical research and development company focused on commercializing proprietary product candidates for the treatment o...

Glycominds and Fox Chase Cancer Center Announce a Collaboration to Discover New Cancer Detection Diagnostic Tests

LOD, Israel, October 25 /PRNewswire/ -- Glycominds Ltd., a bio-diagnostics company specializing in glycan biomarkers for diagnosis and disease management of autoimmune diseases and cancer, announced today entering into a research agreement with Fox Chase Cancer Center (FCCC), an NCI designated...

Researchers underscore limitations of genetic ancestry tests

AUSTIN, TexasAlthough many people rely on commercially available genetic tests for insights into their ancestry, the tests have significant limitations according to Deborah Bolnick, assistant professor of anthropology at The University of Texas at Austin. In The Science and Business of Genetic...

BioReliance Corporation Launches iNet(TM) for Online Results Tracking of Biological Safety Tests

ROCKVILLE, Md., Sept. 18 /PRNewswire/ -- BioReliance Corporation, a leading contract services organization for the biopharmaceutical and pharmaceutical industries, announced today the launch of iNet, a proprietary information technology system that enables customers to submit test article deta...

Quintessence division to develop drug tests with NIH grant

Madison, Wis. — QBI Life Sciences said it has received $175,000 from the National Institutes of Health and formed partnerships with UW-Madison and the University of Helsinki, Finland, to develop new drug tests. QBI, a division of Quintessence Biosciences Inc. in Madison, will be workin...

UW tests adult stem cell role in regenerative heart care

Madison, Wis . - Can a heart patient's own stem cells be used to repair heart damage? The University of Wisconsin School of Medicine and Public Health intends to find out as part of a clinical trial now underway at UW Hospital and Clinics . The school is among the first medical centers in...

Protein Truncation Tests Using the DCode System

Helen Chun, Milhan Telatar and Richard A. Gatti Department of Pathology, UCLA School of Medicine, Los Angeles, California Introduction Protein Truncation Testing (PTT) is a method used to screen large coding regions of DNA to detect ...

Southwestern lab selects Third Wave reagents for Hepatitis tests

MADISON, Wis. Third Wave Technologies Inc. has announced that the southwestern laboratory network TriCore Reference Laboratories has adopted Third Wave's Invader Hepatitis C Virus genotyping reagents. The reagents are part of tests that can identify all six types of the Hepatitis C virus, a...

Viral Genetics Creates Subsidiary to Develop Cancer Therapy

...to commercialization of VGV-1 in the United States, the obtaining of funding required to carry out the development plan, the completion of studies and tests on time or at all, and the successful outcome of such studies or tests. Therefore, there can be no assurance that the forward-looking statements inclu...

SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights

...sed to introduce a series of molecular diagnostics tests to the market, including the first of those based ...HD and fetal sex determination. The first of these tests - CFTR - is expected to launch this quarter or ear... next quarter. The RHD and fetal sex determination tests are on target for launches thereafter. Dow...

Webcast Alert: Transgenomic Inc. Announces Second Quarter 2009 Earnings Release Conference Call Webcast

...ize these technologies and expertise to provide a menu of mutation scanning tests for over 700 cancer-associated genes and more than 60 validated diagnostic tests to meet the needs of pharmaceutical and biotech companies, research and cli...

BioNeutral's Ygiene(TM) Hospital Grade Antimicrobial Proven To Be Completely Inert to Steel In Independent Corrosion Testing

... More information about the Company may be found at www.bioneutralgroup.com . Forward-Looking Statements BioNeutral routinely tests its formulations against those of its competitors. The results are published to let shareholders know how BioNeutral's technology compares with known...

Genomic Health Announces Second Quarter 2009 Financial Results and Business Progress

...are making to develop and commercialize additional tests to personalize the treatment of cancer. Since 200...he development and commercialization of additional tests to personalize the treatment of cancer; the compan...ufficient levels of reimbursement for our existing tests and any future...